Clinical meetings

← vista completa

Published on February 1, 2010 | http://doi.org/10.5867/medwave.2010.02.4375

New pneumococcal conjugate vaccines: revisiting their success

Nuevas vacunas antineumocócicas conjugadas: recorriendo su éxito…

Juanita Zamorano

This work is licensed under a Creative Commons Attribution 4.0 International License. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Authors

Juanita Zamorano

Hospital Padre Hurtado, Clínica Santa María, Santiago, Chile

Figures

Article has no figures.

Forum

No messages

History

Citation Zamorano J. New pneumococcal conjugate vaccines: revisiting their success. Medwave 2010;10(2):e4375 doi: 10.5867/medwave.2010.02.4375

Submission date 01/01/1970

Acceptance date 01/01/1970

Publication date 01/02/2010

Index

Metrics

Not available at the moment.

Notes

References

  1. Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med. 2006 Apr 6;354(14):1455-63. | CrossRef | PubMed
  2. Centers for Disease Control and Prevention (CDC). Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003. MMWR Morb Mortal Wkly Rep. 2005 Sep 16;54(36):893-7. | PubMed
  3. Albrich WC, Madhi SA, Lafond KE, Klugman KP. Herd immunity after pneumococcal conjugate vaccination. Lancet. 2007 Jul 21;370(9583):218-9; author reply 219-20. | CrossRef | PubMed
  4. Madhi SA, Klugman KP; Vaccine Trialist Group. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med. 2004 Aug;10(8):811-3. Epub 2004 Jul 11. | CrossRef | PubMed
  5. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000 Mar;19(3):187-95. | CrossRef | PubMed
  6. McEllistrem MC, Adams JM, Patel K, Mendelsohn AB, Kaplan SL, Bradley JS, et al. Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2005 Jun 15;40(12):1738-44. Epub 2005 May 11. | CrossRef | PubMed
  7. Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J. 2004 Sep;23(9):824-8. | CrossRef | PubMed
  8. Grijalva CG, Poehling KA, Nuorti JP, Zhu Y, Martin SW, Edwards KM, et al. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics. 2006 Sep;118(3):865-73. | CrossRef | PubMed
  9. OMS. Serie de Reportes Técnicos. 2005(927):Anexo 2. | Link
  10. Shao PL, Lu CY, Chang LY, Huang FY, Lee CY, Hsueh PR, et al. Safety and immunogenicity of heptavalent pneumococcal conjugate vaccine booster in taiwanese toddlers. J Formos Med Assoc. 2006 Jul;105(7):542-9. | CrossRef | PubMed